Torthaí cuardaigh - Brad Schenkel

  • 1 - 3 toradh as 3 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Íomhá chlúdaigh

    Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis de réir Neal Bhatia, Jayme Heim, Brad Schenkel, J. Gabriel Vasquez

    Foilsithe / Cruthaithe 2023
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Íomhá chlúdaigh

    Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting de réir Neal Bhatia, Jayme Heim, J. Gabriel Vasquez, Tina Bhutani, Brad Schenkel, Ranga Gogineni, John Koo

    Foilsithe / Cruthaithe 2024
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Íomhá chlúdaigh

    Development of a patient-reported outcome questionnaire for use in adults with moderate-to-severe plaque psoriasis: The Psoriasis Symptoms and Signs Diary de réir Steven R. Feldman, Susan D. Mathias, Brad Schenkel, Hilary H. Colwell, Kelly McQuarrie, Bruce Randazzo, Chenglong Han

    Foilsithe / Cruthaithe 2016
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: